BioAsia 2023, the state government’s signature event, is shaping up to be a continuation of the pattern seen during the World Economic Forum in Davos, when several eminent international companies came forward to declare their investment plans and growth projects in Telangana. Along with vaccine manufacturer Sanofi, multinational conglomerate Welspun, and major players in the pharmaceutical and life sciences industries Bristol Myers Squibb, Sanofi, and Welspun, who all announced their plans for Telangana earlier this week, Jubilant Bhartia Group announced that it would build a cutting-edge facility in Hyderabad’s Genome Valley. The announcement was made after Industries Minister KT Rama Rao met with Hari S Bhartia, Founder and Co-Chairman, Jubilant Bhartia Group at the BioAsia 2023 event.